Metraipolis › archive › dc_08781bbeefff

Reimagining Oncologic Drugs in Atherosclerosis: Emerging Mechanisms and Therapeutic Potential — Europe PMC PMID:41007845

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41007845
DOI: 10.3390/biomedicines13092282
License (as archived): solo-consultazione
Archived: 2026-11-09T22:00:05.364Z
SHA-256 of the archived text: 30487286c1cff3e1b29dfa94cc63bf090e0263811f1fbe0b662b6fc0947cbd03
Stable URL of this page: https://metraipolis.com/documento/dc_08781bbeefff

How to cite

Reimagining Oncologic Drugs in Atherosclerosis: Emerging Mechanisms and Therapeutic Potential — Europe PMC PMID:41007845 — Europe PMC (en), https://europepmc.org/article/MED/41007845 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08781bbeefff (Metraipolis archive dc_08781bbeefff, sha256 30487286c1cff3e1b29dfa94cc63bf090e0263811f1fbe0b662b6fc0947cbd03)

BibTeX

@misc{dc08781bbeefff,
  title = {Reimagining Oncologic Drugs in Atherosclerosis: Emerging Mechanisms and Therapeutic Potential — Europe PMC PMID:41007845},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41007845},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08781bbeefff; sha256 30487286c1cff3e1b29dfa94cc63bf090e0263811f1fbe0b662b6fc0947cbd03},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41007845. Agents can read the archived copy with the MCP tool read_document.